Investor Relations
Company Overview
Vascular Solutions, Inc. (NASDAQ: VASC) is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of three major categories: hemostat (blood clotting) products, catheter products and vein products. Vascular Solutions delivers its proprietary and distributed products to interventional cardiologists, interventional radiologists and vascular surgeons through its direct U.S. sales force and international distributor network.
You can request an investor information packet or additional information by filling out our contact form. If you need additional information or have further questions, please contact investor relations at 763.656.4300 or irelations@vasc.com.
SEC forms, including 10-K, 8-K, 10-Q, Form 5, Form 4 and others can be found by clicking on the “SEC Filings” link to the right.
Stock Exchange Listing
Our stock trades on the NASDAQ National Market under the symbol VASC.
“Forward Looking Statements”
The information in (or directly accessible from) this website contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with our limited operating history, defense of patent infringement lawsuits, adoption of our new sealing methodology, lack of profitability, lack of experience with a direct sales force, exposure to possible product liability claims, the development of new products by others, dependence on third-party distributors in international markets, doing business in international markets, limited manufacturing experience, the availability of third party reimbursement, actions by the FDA related to our products, and the loss of key vendors.